The sulfiredoxin-peroxiredoxin redox system regulates the stemness and survival of colon cancer stem cells

Cancer stem cells (CSCs) initiate tumor formation and are known to be resistant to chemotherapy. A metabolic alteration in CSCs plays a critical role in stemness and survival. However, the association between mitochondrial energy metabolism and the redox system remains undefined in colon CSCs. In this study, we assessed the role of the Sulfiredoxin-Peroxiredoxin (Srx-Prx) redox system and mitochondrial oxidative phosphorylation (OXPHOS) in maintaining the stemness and survival of colon CSCs. Notably, Srx contributed to the stability of PrxI, PrxII, and PrxIII proteins in colon CSCs. Increased Srx expression promoted the stemness and survival of CSCs and was important for the maintenance of the mitochondrial OXPHOS system. Furthermore, Nrf2 and FoxM1 led to OXPHOS activation and upregulated expression of Srx-Prx redox system-related genes. Therefore, the Nrf2/FoxM1-induced Srx-Prx redox system is a potential therapeutic target for eliminating CSCs in colon cancer. [Display omitted] •CSCs initiate tumor formation and are known to be resistant to chemotherapy.•We assessed the role of the Srx-Prx redox system and OXPHOS in colon CSCs.•Srx contributed to the stability of PrxI, PrxII, and PrxIII proteins in colon CSCs.•Nrf2 and FoxM1 upregulated Srx-Prx redox system-related gene expression.•Nrf2/FoxM1-induced Srx-Prx redox system is a target to eliminate CSCs in colon cancer.